Results 241 to 250 of about 39,875 (271)
Some of the next articles are maybe not open access.
Treatment of Duchenne's Muscular Dystrophy
JAMA: The Journal of the American Medical Association, 1982To the Editor.— The recent article by Crisp and colleagues (1982;247:478) and the accompanying editorial by Shelborne (1982;247:496), both of which emphasize the value of early diagnosis in Duchenne's muscular dystrophy (DMD), are highly commendable and may help to prevent needless tragedy and suffering.
openaire +2 more sources
Pharmacotherapy of Duchenne Muscular Dystrophy
2019Drug development and pharmacotherapy of rare pediatric diseases have significantly expanded over the last decade, in part due to incentives and financial support provided by governments, regulators, and nonprofit foundations. Duchenne muscular dystrophy (DMD) is among the most common rare pediatric disorders, and clinical trials of therapeutic ...
openaire +2 more sources
miRNAs as serum biomarkers for Duchenne muscular dystrophy
EMBO Molecular Medicine, 2011Davide Cacchiarelli +2 more
exaly
Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy
Journal of Cell Biology, 2014Zuyi Wang +2 more
exaly
Prevention of Pulmonary Morbidity for Patients With Duchenne Muscular Dystrophy
Chest, 1997John R Bach +2 more
exaly
Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary
American Journal of Respiratory and Critical Care Medicine, 2017OSCAR Henry Mayer +2 more
exaly
Disparities in the diagnostic process of Duchenne and Becker muscular dystrophy
Genetics in Medicine, 2011F John Meaney +2 more
exaly